Literature DB >> 24561308

Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.

Mariana M Mata1, Fareeha Mahmood1, Ryan T Sowell1, Linda L Baum2.   

Abstract

Freshly isolated PBMC are broadly used as effector cells in functional assays that evaluate antibody-dependent cell mediated cytotoxicity (ADCC) and NK activity; however, they introduce natural-individual donor-to-donor variability. Cryopreserved PBMC provide a more consistent source of effectors than fresh cells in cytotoxicity assays. Our objective was to determine the effects of cryopreservation of effector PBMC on cell frequency, and on the magnitude and specificity of ADCC and NK activity. Fresh, frozen/overnight rested and frozen/not rested PBMC were used as effector cells in (51)Cr-release and CD107a degranulation assays. Frozen/overnight rested PBMC had higher ADCC and NK activity in both assays when compared to fresh PBMC; however, when using frozen/not rested PBMC, ADCC and NK activities were significantly lower than fresh PBMC. Background CD107a degranulation in the absence of target cell stimulation was greater in PBMC that were frozen/not rested when compared to fresh PBMC or PBMC that were frozen overnight and rested. The percentages of CD16(+)CD56(dim) NK cells and CD14(+) monocytes were lower in PBMC that were frozen and rested overnight than in fresh PBMC. CD16 expression on CD56(dim) NK cells was similar for all PBMC treatments. PBMC that were frozen and rested overnight were comparable to fresh PBMC effectors. PBMC that were frozen and used immediately when evaluating ADCC or NK activity using either a (51)Cr-release assay or a CD107a degranulation assay had the lowest activity. Clinical studies of antibodies that mediate ADCC would benefit from using effector cells that have been frozen, thawed and rested overnight prior to assay.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADCC; CD107a; Cryopreservation; Degranulation; NK cells; PBMC

Mesh:

Substances:

Year:  2014        PMID: 24561308      PMCID: PMC4029863          DOI: 10.1016/j.jim.2014.01.017

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  34 in total

1.  NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

Authors:  Susanne E Johansson; Erik Rollman; Amy W Chung; Rob J Center; Bo Hejdeman; Ivan Stratov; Jorma Hinkula; Britta Wahren; Klas Kärre; Stephen J Kent; Louise Berg
Journal:  Viral Immunol       Date:  2011-09-29       Impact factor: 2.257

2.  A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.

Authors:  Wannee Kantakamalakul; Kovit Pattanapanyasat; Surat Jongrakthaitae; Vatcharain Assawadarachai; Silawun Ampol; Ruengpung Sutthent
Journal:  J Immunol Methods       Date:  2006-07-17       Impact factor: 2.303

3.  HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.

Authors:  L L Baum; K J Cassutt; K Knigge; R Khattri; J Margolick; C Rinaldo; C A Kleeberger; P Nishanian; D R Henrard; J Phair
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

Authors:  M A Cooper; T A Fehniger; S C Turner; K S Chen; B A Ghaheri; T Ghayur; W E Carson; M A Caligiuri
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

Review 5.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

6.  In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

Authors:  Olivier Manches; Gabrielle Lui; Laurence Chaperot; Rémy Gressin; Jean-Paul Molens; Marie-Christine Jacob; Jean-Jacques Sotto; Dominique Leroux; Jean-Claude Bensa; Joël Plumas
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

7.  Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection.

Authors:  Qingquan Liu; Yongtao Sun; Suzannah Rihn; Anne Nolting; Peter Nicholas Tsoukas; Stephanie Jost; Kristen Cohen; Bruce Walker; Galit Alter
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  The standardization of NK cell assays for use in studies of biological response modifiers.

Authors:  H F Pross; J A Maroun
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

9.  Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.

Authors:  Mariana M Mata; Joyce R Iwema; Shanna Dell; Leslie Neems; Beth D Jamieson; John Phair; Mardge H Cohen; Kathryn Anastos; Linda L Baum
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-18       Impact factor: 2.205

10.  Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells.

Authors:  Timothy Kute; John R Stehle; David Ornelles; Natalie Walker; Osvaldo Delbono; James P Vaughn
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

View more
  21 in total

Review 1.  Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.

Authors:  Marcela K Preininger; Monalisa Singh; Chunhui Xu
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 2.  Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.

Authors:  Xue Yao; Sandro Matosevic
Journal:  BioDrugs       Date:  2021-08-24       Impact factor: 5.807

3.  Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants.

Authors:  Chia-Hsing Pi; Kathlyn Hornberger; Peter Dosa; Allison Hubel
Journal:  Cytotherapy       Date:  2020-03-25       Impact factor: 5.414

4.  Algorithm-driven optimization of cryopreservation protocols for transfusion model cell types including Jurkat cells and mesenchymal stem cells.

Authors:  Kathryn Pollock; Joseph W Budenske; David H McKenna; Peter I Dosa; Allison Hubel
Journal:  J Tissue Eng Regen Med       Date:  2016-05-27       Impact factor: 3.963

Review 5.  Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.

Authors:  Diogo Gomes-Silva; Carlos A Ramos
Journal:  Biotechnol J       Date:  2017-10-30       Impact factor: 4.677

6.  Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) in Familial Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Alexander P Sung; Jennifer J-J Tang; Michael J Guglielmo; Julie Smith-Gagen; Lucinda Bateman; Lydia Navarrete-Galvan; Doug D Redelman; Dorothy Hudig
Journal:  Fatigue       Date:  2021-02-02

7.  NANOPARTICLE-MEDIATED DELIVERY OF CRYOPROTECTANTS FOR CRYOPRESERVATION.

Authors:  Samantha Stewart; Alyssa Arminan; Xiaoming He
Journal:  Cryo Letters       Date:  2020 Nov-Dec       Impact factor: 0.892

8.  High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.

Authors:  Sarah M McAlpine; Sarah E Roberts; John J Heath; Fabian Käsermann; Andrew C Issekutz; Thomas B Issekutz; Beata Derfalvi
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters.

Authors:  Mariam Aziz; Fareeha Mahmood; Mariana Mata; Helen G Durkin; Chenglong Liu; Ruth M Greenblatt; Marek Nowicki; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Linda L Baum
Journal:  J AIDS Clin Res       Date:  2015-07-09

10.  miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells.

Authors:  Sofia E Gomes; André E S Simões; Diane M Pereira; Rui E Castro; Cecília M P Rodrigues; Pedro M Borralho
Journal:  Oncotarget       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.